Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
Clinical trial NCT05332210 · COMPLETED
Trial details
- NCT number
- NCT05332210
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-04-26
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.